Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Benign Hematology
•
Von Willebrand
How do you manage bleeding or peri-procedural care for vWD patients whose vWF levels have increased or normalized from age or hormonal contraceptive use?
How do you think about removing the vWD diagnosis if levels have normalized from age?
Related Questions
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
How do you treat factor XI deficient patients with surgery or trauma related bleeding?
How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?
How do you manage a subchorionic hematoma in type 1 von Willebrand disease, with borderline normal levels of vWF?
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
What experience have you had with familial clustering of polycythemia vera?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?